Paul Hartmann AG (PHH2) - Total Liabilities
Based on the latest financial reports, Paul Hartmann AG (PHH2) has total liabilities worth €978.01 Million EUR (≈ $1.14 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Paul Hartmann AG (PHH2) cash flow conversion to assess how effectively this company generates cash.
Paul Hartmann AG - Total Liabilities Trend (2013–2024)
This chart illustrates how Paul Hartmann AG's total liabilities have evolved over time, based on quarterly financial data. Check PHH2 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Paul Hartmann AG Competitors by Total Liabilities
The table below lists competitors of Paul Hartmann AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Shineway Pharmaceutical Group Limited
F:C1S
|
Germany | €2.58 Billion |
|
TOA Paint (Thailand) Public Company Limited
BK:TOA
|
Thailand | ฿6.22 Billion |
|
Mahindra Lifespace Developers Limited
NSE:MAHLIFE
|
India | Rs48.12 Billion |
|
First Financial Corporation Indiana
NASDAQ:THFF
|
USA | $5.11 Billion |
|
Hoang Anh Gia Lai JSC
VN:HAG
|
Vietnam | ₫12.71 Trillion |
|
Inox Green Energy Services Limited
NSE:INOXGREEN
|
India | Rs4.38 Billion |
|
Verusa Holding AS
IS:VERUS
|
Turkey | TL1.18 Billion |
|
WELL Health Technologies Corp
TO:WELL
|
Canada | CA$1.17 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Paul Hartmann AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Paul Hartmann AG worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Paul Hartmann AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Paul Hartmann AG (2013–2024)
The table below shows the annual total liabilities of Paul Hartmann AG from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €901.80 Million ≈ $1.05 Billion |
+3.51% |
| 2023-12-31 | €871.24 Million ≈ $1.02 Billion |
-0.75% |
| 2022-12-31 | €877.81 Million ≈ $1.03 Billion |
+19.91% |
| 2021-12-31 | €732.05 Million ≈ $855.85 Million |
-3.32% |
| 2020-12-31 | €757.19 Million ≈ $885.23 Million |
+11.85% |
| 2019-12-31 | €676.95 Million ≈ $791.43 Million |
+17.49% |
| 2018-12-31 | €576.16 Million ≈ $673.59 Million |
-0.17% |
| 2017-12-31 | €577.13 Million ≈ $674.73 Million |
+12.47% |
| 2016-12-31 | €513.13 Million ≈ $599.90 Million |
-1.23% |
| 2015-12-31 | €519.52 Million ≈ $607.37 Million |
-6.70% |
| 2014-12-31 | €556.83 Million ≈ $650.99 Million |
+3.17% |
| 2013-12-31 | €539.74 Million ≈ $631.01 Million |
-- |
About Paul Hartmann AG
Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management p… Read more